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Obesity is a major risk factor for poorly controlled asthma, but the reasons for poor asthma
control in this patient population are unclear. Symptoms of depression have been associated
with poor asthma control, and increase with higher body mass index (BMI). The purpose of this
study was to assess whether depressive symptoms underlie poor asthma control in obesity.
Methods: We determined the relationship between BMI, psychological morbidity and asthma
control at baseline in a well-characterized patient population participating in a clinical trial
conducted by the American Lung Association-Asthma Clinical Research Centers.
Results: Obese asthmatic participants had increased symptoms of depression (Center for
Epidemiologic Studies Depression Scale score in lean 10.1  8.1, overweight 10.0  8.1, obese
12.4  9.9; p Z 0.03), worse asthma control (Juniper Asthma Control Questionnaire score in
lean 1.43  0.68, overweight 1.52  0.71, obese 1.76  0.75; p < 0.0001), and worse asthma
quality of life (scores in lean 5.21  1.08, overweight 5.08  1.05, obese 4.64  1.09;
p < 0.0001). Asthmatics with obesity and those with symptoms of depression both had a higher
risk of having poorly controlled asthma (adjusted odds ratio of 1.83 CI 1.23e3.52 for obesity,
and 2.08 CI 1.23e3.52 for depression), but there was no interaction between the two.of Medicine, University of Vermont and Fletcher Allen Health Care, Given D209, 89 Beaumont Avenue,
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Obesity and symptoms of depression 1101Conclusion: Obesity and symptoms of depression are independently associated with poor
asthma control. As depression is increased in obese asthmatics it may be an important co-
morbidity contributing to poor asthma control in this population, but factors other than
depression also contribute to poor asthma control in obesity.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Obesity is a significant risk factor for developing asthma
and is associated with poor asthma control [1,2]. Depres-
sion and anxiety are likewise associated with poor asthma
control, and the prevalence of depression and anxiety are
dramatically increased in obesity. The underlying interac-
tion between obesity, depression, and asthma is not well
understood, yet may have critical implications for asthma
control in the setting of obesity.
Obesity is associated with decreased responsiveness to
controller medication and poor asthma control [3]. One
study found that obese asthmatics are hospitalized at
nearly five times the rate of lean asthmatics [4]. Given the
ever increasing prevalence of obesity [5], obesity is
contributing to an epidemic of poorly controlled asthma.
A number of studies suggest that anxiety and depression
adversely affect asthma symptom severity and there is a
significant correlation between severity of depressive
symptoms and poor asthma control [6,7]. Depressed asth-
matics also have an increased risk of asthma-related
emergency department visits and poor adherence to
asthma medication regimens [8].
Depression is a very common comorbidity associated
with obesity [9]. The strong association between high BMI
and depressive symptoms is more pronounced in women,
the demographic group with the highest rate of asthma
related to obesity [3]. This relationship is reversible as
weight reduction surgery significantly reduces symptoms of
anxiety and depression among obese asthmatics [10], this
surgery also improves asthma control [11]. Considering that
depression is increased in obesity, such psychological co-
morbidity may contribute significantly to the poor asthma
control characteristic of obese asthmatics.
The purpose of this study was first to determine if
depression and obesity were associated with poor asthma
control, and then to determine if depression could explain
poor asthma control in obesity. We evaluated the rela-
tionship of both markers of depression and measures of
asthma control with obesity, hypothesizing that a signifi-
cant interaction between obesity and depression would
contribute to worse asthma control among obese asth-
matics. This study was completed in a well characterized,
patient population participating in a clinical trial of the
placebo response in asthma.
Methods
Data on obesity and symptoms of depression were derived
from participants in a multicenter clinical trial designed to
assess the placebo effect in asthma performed by the
American Lung Association Asthma Clinical ResearchCenters. Details of the main study and eligibility criteria
have been published elsewhere, and are summarized below
[12]. The study was approved by the Institutional Review
Boards at all participating centers, and all participants
signed informed consent.
Males and females at least 15 years of age who had been
diagnosed with asthma by a physician, regularly used any
prescribed asthma medication in the last 12 months, and
had a post-bronchodilator forced expiratory volume (FEV1)
75% predicted were included in the trial. Participants had
inadequate control of asthma symptoms indicated by one of
the following: short-acting b2 agonist use two or more
times per week for relief of asthma symptoms, nocturnal
awakenings once or more per week due to asthma symp-
toms, or a Juniper Asthma Control Questionnaire (ACQ)
score of 1.5 at their enrollment visit.
Participants were excluded if they had a significant
smoking history (10 pack years or active smoking in the
past 6 months), or had used montelukast or other leuko-
triene antagonists within the past 14 days. Participants
were also excluded if they reported a history of hospitali-
zation, emergency department visits, or prednisone use for
asthma within the past 3 months, past respiratory failure
secondary to asthma, or prior adverse reaction to mon-
telukast. At baseline, participants were extensively evalu-
ated for their asthma characteristics with the Juniper
Asthma Control Questionnaire [13], and the Juniper Asthma
Quality of Life Questionnaire [14]. Spirometry was per-
formed according to ATS guidelines [15]. Symptoms of
depression were measured by the Center for Epidemiolog-
ical Studies Depression Score (CES-D) [16,17]. Participants’
asthma knowledge and sense of asthma self-efficacy were
measured by the Knowledge, Attitude, and Self-efficacy
Asthma Questionnaire (KASE-AQ) [18].Statistical approach
Descriptive statistics were used to summarize baseline
characteristics of the study subjects, divided into three
categories according to body mass index (BMI): lean (BMI
18.5e24.9 kg/m2), overweight (BMI 25e29.9 kg/m2), and
obese (BMI  30 kg/m2). Continuous variables were
compared using analysis of variance, with log trans-
formations for non-parametric variables, and proportions
were compared using c2 analysis. Post-hoc comparison of
groups was performed using the Bonferroni procedure.
We determined the risk of poor asthma control associ-
ated with obesity (defined as a BMI  30) compared to non-
obese (defined as those with a BMI < 30) and depression
(defined as a CES-D score  16 compared to those with a
score < 16). We performed multiple logistic regression
including sex, age, race, education, income and
1102 S.G. Kapadia et al.employment status in the final model. We evaluated the
relationship between asthma control and symptoms of
depression, using an interaction term for obesity
(BMI > 30 kg/m2) and significant symptoms of depression
(defined as a CES-D score  16). Analyses were performed
with STATA 10$0 (College Station, Texas).
Role of funding source
The study sponsors had no role in study design, data
collection, data analysis, data interpretation or decision to
submit manuscript. The corresponding author had full ac-
cess to all the data, and the final responsibility for the
decision to submit for publication.
Results
Participant characteristics
A total of 601 unique participants were enrolled in the
primary study. Participant demographic characteristicsTable 1 Baseline characteristics of participants.
Lean Ov
n (%) 205 (34%) 164
Demographic characteristics
Age (years) 32.4  13.3 40.
BMI (kg/m2) 22.3 (20.9e23.7) 27.
Women 140 (68) 106
Race or ethnic group (%)
White 144 (69) 104
Black 45 (22) 54
Hispanic 6 (3) 1 (
Other 10 (6) 5 (
Highest level of education (%)
<High school 19 (9) 11
High school 20 (10) 22
Some college 81 (39) 62
Bachelor’s degree 48 (23) 38
Some post-graduate 15 (7) 10
Post-graduate degree 22 (11) 21
Employment status (%)
Student 64 (30) 19
Not working 16 (8) 15
Full time 86 (42) 94
Part time 25 (12) 16
Retired 6 (3) 12
Disabled 3 (1) 3 (
Other 5 (2) 5 (
Household income (%)
<$20,000 48 (23) 21
$20,000e$50,000 57 (28) 52
$50,000e$75,000 24 (12) 21
>$75,000 23 (11) 23
Declined to answer 37 (18) 36
Don’t know 16 (8) 11
Values shown are mean  SD or median (IQR) for continuous variable
P values shown are for analysis of variance for continuous variables,
*P < 0.05 compared with lean group.are summarized in Table 1. The mean age of participants
was 32 years in the lean group, overweight and obese
asthmatic participants were significantly older. Most par-
ticipants were female, constituting nearly 82% of the
obese group. There was a higher proportion of African
American participants in the obese category. Obese asth-
matics reported completing less education than leaner
participants, though there was no overall difference in
reported income. Employment status differed among the
BMI categories, with a higher proportion of students in the
lean category.
Asthma characteristics
Data on asthma characteristics in the distinct BMI groups
are reported in Table 2. Obese and overweight asthmatics
reported significantly later-onset asthma than lean asth-
matics. Obese asthmatics tended to report more frequent
use of oral prednisone for asthma. Obese participants had
worse asthma control as assessed by the Juniper Asthma
Control Questionnaire (ACQ) and worse asthma-related
quality of life as assessed by the Asthma Quality of Lifeerweight Obese p Value
(27%) 232 (39%)
5  14.9* 41.1  12.6* <0.0001
2 (26.0e28.3) 35.0 (32.6e41.1) <0.001
(63) 191 (82)
(64) 114 (49) <0.001
(32) 102 (44)
1) 1 (0)
3) 15 (7)
(7) 19 (8) <0.001
(13) 45 (20)
(37) 117 (50)
(23) 27 (12)
(6) 11 (5)
(13) 13 (6)
(12) 16 (7) <0.001
(9) 30 (13)
(57) 114 (49)
(9) 29 (13)
(7) 12 (5)
2) 19 (8)
3) 12 (5)
(13) 59 (25) 0.22
(31) 74 (32)
(13) 23 (10)
(14) 20 (9)
(22) 42 (18)
(7) 14 (6)
s, and n (%) for proportions.
and c2 test for proportions.
Table 2 Asthma characteristics & pulmonary function.
Lean Overweight Obese p Value
Age asthma onset (years) 14.9  16.7 21.7  22.7c 22.1  20.8c 0.0001
Pack years 3.6  2.8 4.1  3.0 4.0  3.1 0.8
Number of courses of prednisone use in last 12 months (n{%})
0 177 (78) 146 (77) 183 (69) 0.09
1 32 (14) 28 (15) 45 (17)
2 17 (8) 15 (8) 36 (14)
Asthma questionnaires , mean ± SD
ACQ (Y score range, 0e6)a 1.43  0.68 1.52  0.71 1.76  0.75c,d <0.0001
AQLQ ([ score range, 1e7)a 5.21  1.08 5.08  1.05 4.64  1.09c,d <0.0001
Pulmonary function measures, mean ± SD
PEF (L/min) 404.2  96.1 398.6  95.1 385.9  93.4 0.12
FEV1 (% predicted pre BD)
b 88.4  13.5 85.6  13.2 84.6  13.4c 0.01
FVC (% predicted pre BD)b 97.7  13.0 94.4  12.8c 91.8  13.0c <0.0001
FEV1/FVC (pre BD) 75.6  9.2 74.3  9.1 75.7  7.6 0.16
FEV1 % change after BD 8.9  10.2 9.9  10.9 8.8  13.0 0.63
FVC % change after BD 2.5  6.1 4.5  9.1c 4.5  11.1c <0.001
Values shown are mean and SD, and are compared by analysis of variance and n (%) for proportions.
ACQ, asthma control questionnaire; AQLQ, asthma quality of life questionnaire; PEF, morning peak expiratory flow; FEV1, forced
expiratory volume in 1 s; FVC, forced vital capacity; BD, bronchodilator.
a Y, Lower score is better; [ Higher score is better.
b Predicted values for FEV1 and FVC are taken from Hankinson et al. [32].
c p < 0.05 compared with lean group.
d p < 0.01 compared with overweight group.
Table 3 Measures of psychological morbidity.
Lean Overweight Obese p
Value
CES-D (aY score range, 0-60) median (IQR)
8 (4e24) 8 (4e24.5) 10 (5e16) 0.03
CES-D level of depressionb n (%)
CES-D no
depression
163 (80) 129 (79) 169 (73) 0.01
CES-D mild
symptoms
26 (13) 25 (15) 26 (11)
CES-D
probable
depression
16 (7) 10 (6) 37 (16)
KASE-AQ (a[ score range, 5e100) mean ± SD
Self-efficacy 82.4  8.4 82.8  9.2 79.8  9.3c,d 0.001
Attitude 85.4  7.2 85.5  7.6 85.3  6.4 0.96
Knowledge 12.0  2.8 11.1  2.9c 11.0  3.0c 0.0005
KASE-AQ, knowledge, attitude, and self-efficacy asthma
questionnaire.
a Y, Lower score is better; [, Higher score is better.
b CES-D, center for epidemiologic studies depression scale,
threshold for mild depressive symptoms  16, probable
depression  23.
c p < 0.05 compared to lean group.
d p < 0.05 compared to overweight group.
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weight asthmatics.
Data on pulmonary function are also provided in Table 2,
and differed among participants. Obese asthmatics had
significantly lower FEV1 and FVC than lean asthmatics, and
obese and overweight asthmatics had greater change in FVC
in response to bronchodilator than lean asthmatics.
Psychological morbidity
Obese asthmatics had higher depression scores as assessed
by the Center for Epidemiologic Studies Depression Scale
(CES-D) and more frequently surpassed the reported
thresholds for mild depressive symptoms (a score of 16 and
above) as well as probable depression (a score of 23 and
above) (Table 3) [17]. Obese asthmatics also reported
significantly lower self-efficacy related to asthma
compared with lean and obese asthmatics, and both obese
and overweight asthmatics had lower asthma knowledge, as
assessed by the Knowledge, Attitude, and Self-Efficacy
Asthma Questionnaire (KASE-AQ).
Combined effect of depression and obesity
Both obesity and having symptoms of depression increased
the risk of having poorly controlled asthma, as defined by a
score of 1.5 or greater on the Juniper Asthma Control Score
(311 out of 605 participants had a score of 1.5 or greater
when depression symptoms were assessed at the second
study visit) (Table 4).
When both obesity and depression were considered in
the same model, there was little change in the odds of
having poorly controlled asthma, and the interactionbetween obesity and asthma was not significant (pZ 0.58),
suggesting that obesity and depression contribute inde-
pendently to poor asthma control. Depressed patients had
worse asthma control in all BMI groups, suggesting that the
Table 4 Risk of poor asthma control in those with obesity
and/or depression.
Odds ratio CI
Obesitya 2.06 1.48e2.88
Depressiona 2.44 1.65e3.63
Obesityb 1.83 1.23e3.52
Depressionb 2.08 1.23e3.52
Poor asthma control was defined as a score of 1.5 on the ju-
niper asthma control questionnaire.
a Uni-variate analysis for depression (using threshold of CES-
D  C16) and obesity separately.
b Multivariate analysis combining depression and obesity in
the same model, which also includes age, sex, race, education,
employment, income, and an interaction value for presence of
obesity and depression (p Z 0.58).
1104 S.G. Kapadia et al.contribution of depression to poor asthma control was not
unique to obesity (Table 5).
Discussion
This study demonstrates that obese asthmatics have poor
asthma control, worse asthma-specific quality of life, and
suffer a greater burden of symptoms of depression than
leaner asthmatics. Obesity and symptoms of depression are
both independently related to poor asthma control,
without a significant interaction between the two comor-
bidities. This suggests that depression should be considered
in managing obese patients with poor asthma control as the
prevalence of depression increases with BMI, but that poor
asthma control in obesity is also related to factors other
than depression. This study has important clinical implica-
tions with regard to understanding the physical and mental
underpinnings of poor asthma control among obese
asthmatics.
The present study provides further evidence of the
relationship between obesity and poor asthma control asTable 5 Asthma control in relation to symptoms of
depression in participants of differing BMI groups.
No
depression
Mild
depression
Probable
depression
p
Lean
Asthma
control
1.36  0.67 1.58  0.56 1.89  0.72a <0.01
Overweight
Asthma
control
1.46  0.66 1.62  0.66 1.97  1.21 0.07
Obese
Asthma
control
1.67  0.74 2.05  0.65a 1.96  0.77 0.01
Values shown are mean  SD from ACQ, asthma control ques-
tionnaire.
Mild depression was defined using a threshold of CES-D  16,
probable depression as CES-D  23.
a p < 0.05 compared with lean group.well as worse asthma-related quality of life. Obesity is not
only a risk factor for incident asthma, but is also associ-
ated with worse control characterized by increased
symptoms, more frequent use of rescue bronchodilator
medications, increased risk of hospitalizations for asthma,
and missed work days [2,7,19]. Obesity is a significant
cause of poorly controlled asthma due to many factors
such as altered lung mechanics, altered responses to
medications, elevated airway oxidative stress, effects of
adipokines and cytokines, and other co-morbidities which
occur in obesity such depression and obstructive sleep
apnea [3]. We have previously reported that symptoms of
obstructive sleep apnea are associated with worse asthma
control [20], but few studies have investigated the role of
psychological morbidity in the poor asthma control of
obesity.
Asthmatics are more likely to suffer from anxiety and
depression than the general population, irrespective of BMI
[21]. Data from the 2002 World Health Survey collected by
the World Health Organization across 54 countries sug-
gested that depression was significantly associated with
asthma in 65% of countries [22]. There may be a causal link
between depression and asthma; in a longitudinal 20 year
follow up CARDIA study by Brunner et al., elevated
depressive symptoms were associated with a 1.26 increased
risk of developing incident asthma (independent of BMI)
[23]. Depression in asthmatics has been associated with
poor asthma control [21,24], with one study reporting that
comorbid depression was associated with greater health
care utilization and 51% higher health care costs [25].
Depression may contribute to poor asthma control through
a number of pathways. Asthmatics with psychological co-
morbidity may perceive a greater intensity of breathless-
ness [21]. Asthmatics with depressive symptoms may also
develop cholinergic-mediated airway constriction in the
event of psychological stress [26,27]. Depression may also
affect medication adherence: high levels of depressive
symptoms are associated with an 11-fold increase in odds of
poor adherence (measured electronically) to inhaled
corticosteroid therapy after hospitalization for an asthma
exacerbation [27]. It is also possible that poor asthma
control contributes to the development of depression. In
the current study we found that over 20% of the study
population reached the threshold for mild depression on
the validated CES-D questionnaire, which is in line with
previous reports on the prevalence of depression in asthma
[8,6]. Asthmatic participants with symptoms of depression
were approximately twice as likely to have poor asthma
control as those without symptoms of depression. Our data
provide further evidence that symptoms of depression are
associated with poor asthma control and worse asthma
quality of life.
Many studies suggest there is a significant relationship
between depression and obesity. Meta-analyses of cohort
studies suggest a significant association between obesity
and depression [9,28]; one meta-analysis of 17 community
based studies encompassing 204,507 participants reported
a significant association between depression and obesity,
particularly among females (OR, 1.26; 95% CI, 1.17e1.36)
[9]. Our current study demonstrates that obese asthmatics
had significantly higher scores on the CES-D questionnaire
and a higher prevalence of depression. Many factors may
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Obesity and depression share common risk factors such as
low socioeconomic status and insufficient physical activity
[29]. Psychological distress may be worsened by obesity
because of social stigmatization which produces low self-
worth and self-esteem, a negative body image, guilt, and
peer isolation [9,28,29]. Hypothalamic-pituitary-adrenal
axis dysfunction from psychological distress elevates
circulating cortisol levels which may contribute to abdom-
inal obesity. Depression and obesity likely share common
risk factors and may in part share a common pathophysi-
ology, whether these factors interact with each other to
produce the worse asthma control characteristic of obesity
is not known.
A few studies have addressed the potential for a con-
current interaction between obesity and depression in
mediating poor asthma outcomes. Data collected from the
2006 European National Health and Wellness Survey of
37,476 adults demonstrated that less educated, obese, and
depressed asthmatics experience significantly poorer
asthma control [30]. Acosta-Perez et al. examined the ef-
fects of obesity and depressive/anxiety disorders co-
occurring in a community sample of Puerto Rican youth
10e19 years of age diagnosed with asthma: depression/
anxiety was three times more common in the obese, but
asthma exacerbations were associated with an increased
prevalence of psychological comorbidity among the non-
obese youth only [31]. A recent single center Canadian
study reported that depression appeared to explain poor
asthma control in obese asthmatics, this differs from our
own findings; these differing results are likely related to
differences in the two study patient populations (our own
being a multi-center study with a younger more diverse U.S.
patient population) [32]. Our current study demonstrates a
clinically meaningful effect of obesity and depression
independently contributing to significantly poorer asthma
control. The presence of depression contributed to poor
asthma control in all BMI groups. Contrary to our hypothe-
sis, there was no significant interaction between obesity
and depression, suggesting that the mechanisms linking
depression and asthma are the same in lean patients as
they are in obese patients, though obese patients have a
higher prevalence of depression. Awareness of the finding
that depression contributes to poor asthma control is likely
critical in the management of both lean and obese patients
with asthma.
This study does have some limitations. The patient
population was recruited for a clinical trial and so may not
reflect the general asthma population, although ethnic and
economic diversity in the population was strong. This was a
cross-sectional study, and so we cannot draw any conclu-
sions about the direction of the association between
asthma and depression.
This study shows that depression likely contributes to
poor asthma control in obese patients, as obese patients
have a higher prevalence of depression than lean asth-
matics, and depression is associated with poor asthma
control. However, obesity also contributes to poor asthma
control independent of depression; understanding poor
asthma control in obesity requires research into the path-
ophysiology of airway disease in obesity. This study suggests
that interventions to address psychological comorbidityshould be studied in obese asthmatics, and that improving
asthma control in obese asthmatics will require a holistic
approach to improve asthma outcomes.
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